{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:16:41Z","timestamp":1785741401070,"version":"3.56.0"},"reference-count":103,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>To overcome the limits of traditional antibiotic medications, novel approaches\nare needed to combat the growing global epidemic of Multidrug-resistant (MDR) infections.\nAs drug-resistant bacteria develop, the importance of innovative antimicrobial\nmethods is underscored by antibiotic abuse and misuse. The global threat of MDR microorganisms\nis increasing, which calls for a coordinated global response. Lipid Nanoparticles\n(LNPs) possess several characteristics that make them attractive choices for managing\nmultidrug resistant (MDR) infections, as well as potential delivery systems for\nantimicrobial agents. Thus, LNPs improve drug solubility, stability, and targeted delivery,\nthereby mitigating the drawbacks of conventional antibiotic therapy. Several characteristics\nof LNPs, which stop MDR bacteria from developing resistance mechanisms,\nserve as guidelines for precision medicine. It presents a powerful approach for combating\nthe growing concern of MDR bacteria by increasing Anti-Microbial Peptides (AMPs)\nbioavailability and targeting distribution to bacterial cells. LNPs have the potential to\nredefine antibacterial treatments for MDR illnesses in the context of this study. Further,\nit discusses LNP use in larger applications, such as fighting Anti-Microbial Resistance\n(AMR) and MDR. A complete understanding of the unique features, many uses, and importance\nof collaborative efforts to overcome the global challenge of antibiotic resistance\nare also conveyed in the study.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673314366240712105637","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T07:01:33Z","timestamp":1721286093000},"page":"1488-1506","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revolutionizing Antibacterial Strategies: Lipid Nanoparticles as Game-changers in Combatting Multi-drug-resistant Infections"],"prefix":"10.2174","volume":"32","author":[{"given":"Rihana","family":"Begum P.","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education &amp;\nResearch, Ooty 643 001, The Nilgiris, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-4541","authenticated-orcid":true,"given":"Bhupendra G.","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Shree S. K. Patel\nCollege of Pharmaceutical Education and Research, Ganpat University, Kherva, 384012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rajeshkumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, JSS College of Pharmacy, JSS Academy of Higher Education\nResearch, Ooty 643 001, The Nilgiris, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Balasubramaniam","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Govt.\nMedical College &amp; Hospital, Ooty 643 001, The Nilgiris, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivasankaran","family":"Ponnusankar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education &amp;\nResearch, Ooty 643 001, The Nilgiris, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2021","unstructured":"Global antimicrobial resistance and use surveillance system (&#x200E;GLASS)&#x200E; report: 2022. World Health Organization Available From:     https:\/\/www.who.int\/publications\/i\/item\/97892400627022021"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"Cassini A.","year":"2019","unstructured":"Cassini A.; H&#xF6;gberg L.D.; Plachouras D.; Quattrocchi A.; Hoxha A.; Simonsen G.S.; Colomb-Cotinat M.; Kretzschmar M.E.; Devleesschauwer B.; Cecchini M.; Ouakrim D.A.; Oliveira T.C.; Struelens M.J.; Suetens C.; Monnet D.L.; Strauss R.; Mertens K.; Struyf T.; Catry B.; Latour K.; Ivanov I.N.; Dobreva E.G.; Tambic Andra\u0161evic A.; Soprek S.; Budimir A.; Paphitou N.; &#x17D;emlickov&#xE1; H.; Schytte Olsen S.; Wolff S&#xF6;nksen U.; M&#xE4;rtin P.; Ivanova M.; Lyytik&#xE4;inen O.; Jalava J.; Coignard B.; Eckmanns T.; Abu Sin M.; Haller S.; Daikos G.L.; Gikas A.; Tsiodras S.; Kontopidou F.; T&#xF3;th &#xC1;.; Hajdu &#xC1;.; Gu&#xF3;laugsson &#xD3;.; Kristinsson K.G.; Murchan S.; Burns K.; Pezzotti P.; Gagliotti C.; Dumpis U.; Liuimiene A.; Perrin M.; Borg M.A.; de Greeff S.C.; Monen J.C.M.; Koek M.B.G.; Elstr&#xF8;m P.; Zabicka D.; Deptula A.; Hryniewicz W.; Cani&#xE7;a M.; Nogueira P.J.; Fernandes P.A.; Manageiro V.; Popescu G.A.; Serban R.I.; Schr&#xE9;terov&#xE1; E.; Litvov&#xE1; S.; \u0160tefkovicov&#xE1; M.; Kolman J.; Klavs I.; Koro\u0161ec A.; Aracil B.; Asensio A.; P&#xE9;rez-V&#xE1;zquez M.; Billstr&#xF6;m H.; Larsson S.; Reilly J.S.; Johnson A.; Hopkins S.; Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect Dis  2019,19(1),56-66","journal-title":"Lancet Infect Dis"},{"key":"ref=3","year":"2019","unstructured":"Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention Available From:    https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf2019"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3389\/fmicb.2020.00319","volume":"11","author":"Narayanaswamy V.","year":"2020","unstructured":"Narayanaswamy V.; Torchilin V.P.; Lipid-based nanoparticles in the pharmaceutical industry and translational research. Front Microbiol  2020,11,319","journal-title":"Front Microbiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/ph14111083","volume":"14","author":"Stefanov S.R.","year":"2021","unstructured":"Stefanov S.R.; Andonova V.Y.; Lipid nanoparticulate drug delivery systems: Recent advances in the treatment of skin disorders. Pharmaceuticals  2021,14(11),1083","journal-title":"Pharmaceuticals"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/pharmaceutics15041127","volume":"15","author":"Hajiaghapour Asr M.","year":"2023","unstructured":"Hajiaghapour Asr M.; Dayani F.; Saedi Segherloo F.; Kamedi A.; Neill A.O.; MacLoughlin R.; Doroudian M.; Lipid nanoparticles as promising carriers for mRNA vaccines for viral lung infections. Pharmaceutics  2023,15(4),1127","journal-title":"Pharmaceutics"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","volume":"13","author":"Satapathy M.K.","year":"2021","unstructured":"Satapathy M.K.; Yen T.L.; Jan J.S.; Tang R.D.; Wang J.Y.; Taliyan R.; Yang C.H.; Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics  2021,13(8),1183","journal-title":"Pharmaceutics"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/pharmaceutics13060840","volume":"13","author":"Bukhari S.I.","year":"2021","unstructured":"Bukhari S.I.; Imam S.S.; Ahmad M.Z.; Vuddanda P.R.; Alshehri S.; Mahdi W.A.; Ahmad J.; Recent progress in lipid nanoparticles for cancer theranostics: Opportunity and challenges. Pharmaceutics  2021,13(6),840","journal-title":"Pharmaceutics"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40005-021-00525-z","volume":"51","author":"Thapa R.K.","year":"2021","unstructured":"Thapa R.K.; Diep D.B.; T&#xF8;nnesen H.H.; Nanomedicine-based antimicrobial peptide delivery for bacterial infections: Recent advances and future prospects. J Pharm Investig  2021,51(4),377-398","journal-title":"J Pharm Investig"},{"key":"ref=10","first-page":"125","author":"Jones S","year":"2023","unstructured":"Jones S; Suryaletha K; Savithri AV.;  Nanotechnology Platforms for Antiviral Challenges  2023,125-142","journal-title":"Nanotechnology Platforms for Antiviral Challenges"},{"key":"ref=11","first-page":"145","volume":"6","author":"Gontijo Filho P.P.","year":"2016","unstructured":"Gontijo Filho P.P.; Brito C.S.; Queiroz L.L.; Resende D.S.; Araujo B.F.; Ribas R.M.; Spread of multidrug-resistant microorganisms: A global threat and critical healthcare problem. Revista de Epidemiologia e Controle de Infec&#xE7;&#xE3;o  2016,6(3),145-146","journal-title":"Revista de Epidemiologia e Controle de Infec&#xE7;&#xE3;o"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ccm.2022.06.008","volume":"43","author":"Murray T.S.","year":"2022","unstructured":"Murray T.S.; Stanley G.; Koff J.L.; Novel approaches to multidrug-resistant infections in cystic fibrosis. Clin Chest Med  2022,43(4),667-676","journal-title":"Clin Chest Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"130844","DOI":"10.1016\/j.molstruc.2021.130844","volume":"1243","author":"Karthik V.","year":"2021","unstructured":"Karthik V.; Poornima S.; Vigneshwaran A.; Raj D.P.R.D.D.; Subbaiya R.; Manikandan S.; Saravanan M.; Nanoarchitectonics is an emerging drug\/gene delivery and targeting strategy a critical review. J Mol Struct  2021,1243,130844","journal-title":"J Mol Struct"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/molecules26092671","volume":"26","author":"Terreni M.","year":"2021","unstructured":"Terreni M.; Taccani M.; Pregnolato M.; New antibiotics for multidrug-resistant bacterial strains: Latest research developments and future perspectives. Molecules  2021,26(9),2671","journal-title":"Molecules"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11483-008-9065-8","volume":"3","author":"Weiss J.","year":"2008","unstructured":"Weiss J.; Decker E.A.; McClements D.J.; Kristbergsson K.; Helgason T.; Awad T.; Solid lipid nanoparticles as delivery systems for bioactive food components. Food Biophys  2008,3(2),146-154","journal-title":"Food Biophys"},{"key":"ref=16","author":"Alberts B.","year":"2002","unstructured":"Alberts B.; Johnson A.; Lewis J.; Raff M.; Roberts K.; Walter P.;  Molecular Biology of the Cell  2002","journal-title":"Molecular Biology of the Cell"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-3-030-83395-4_13","author":"Paliwal H","year":"2022","unstructured":"Paliwal H; Prajapati BG; Khunt D; Shirisha C; Patel JK; Pathak YV.;  Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery  2022,245-260","journal-title":"Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2174\/1871520619666190212124944","volume":"19","author":"Kong X","year":"2019","unstructured":"Kong X; Liu Y; Huang X; Huang S; Gao F; Rong P; Zhang S; Zhang K; Zeng W.; Cancer therapy based on smart drug delivery with advanced nanoparticles. Anticancer Agents Med Chem  2019,19(6),720-730","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"114065","DOI":"10.1016\/j.biopha.2022.114065","volume":"157","author":"Liu H.","year":"2023","unstructured":"Liu H.; Zhu X.; Wei Y.; Song C.; Wang Y.; Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems. Biomed Pharmacother  2023,157,114065","journal-title":"Biomed Pharmacother"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbrc.2019.09.017","volume":"519","author":"He H.","year":"2019","unstructured":"He H.; Yao J.; Zhang Y.; Chen Y.; Wang K.; Lee R.J.; Yu B.; Zhang X.; Solid lipid nanoparticles as a drug delivery system to across the blood-brain barrier. Biochem Biophys Res Commun  2019,519(2),385-390","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","volume":"192","author":"Kolate A.","year":"2014","unstructured":"Kolate A.; Baradia D.; Patil S.; Vhora I.; Kore G.; Misra A.; PEG - A versatile conjugating ligand for drugs and drug delivery systems. J Control Release  2014,192,67-81","journal-title":"J Control Release"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/161794","volume":"2014","author":"Torrecilla J.","year":"2014","unstructured":"Torrecilla J.; Rodr&#xED;guez-Gasc&#xF3;n A.; Solin&#xED;s M.&#xC1;.; del Pozo-Rodr&#xED;guez A.; Lipid nanoparticles as carriers for RNAi against viral infections: Current status and future perspectives. BioMed Res Int  2014,2014,1-17","journal-title":"BioMed Res Int"},{"key":"ref=23","first-page":"559","volume":"7","author":"Bhattacharya S.","year":"2015","unstructured":"Bhattacharya S.; Prajapati B.G.; Recent excavations on cationic solid lipid nano particles. J Chem Pharm Res  2015,7(10),559-563","journal-title":"J Chem Pharm Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.omtm.2020.07.015","volume":"18","author":"Liu C.","year":"2020","unstructured":"Liu C.; Zhang L.; Zhu W.; Guo R.; Sun H.; Chen X.; Deng N.; Barriers and strategies of cationic liposomes for cancer gene therapy. Mol Ther Methods Clin Dev  2020,18,751-764","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"Torchilin V.P.","year":"2005","unstructured":"Torchilin V.P.; Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov  2005,4(2),145-160","journal-title":"Nat Rev Drug Discov"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/molecules27051543","volume":"27","author":"Madkhali O.A.","year":"2022","unstructured":"Madkhali O.A.; Perspectives and prospective on solid lipid nanoparticles as drug delivery systems. Molecules  2022,27(5),1543","journal-title":"Molecules"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s40005-016-0260-1","volume":"46","author":"Kim J.S.","year":"2016","unstructured":"Kim J.S.; Liposomal drug delivery system. J Pharm Investig  2016,46(4),387-392","journal-title":"J Pharm Investig"},{"key":"ref=28","author":"Szoka FC.","year":"1991","unstructured":"Szoka FC.;  Membrane Fusion  1991","journal-title":"Membrane Fusion"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","volume":"60","author":"Masood F.","year":"2016","unstructured":"Masood F.; Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C  2016,60,569-578","journal-title":"Mater Sci Eng C"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","volume":"159","author":"Witzigmann D.","year":"2020","unstructured":"Witzigmann D.; Kulkarni J.A.; Leung J.; Chen S.; Cullis P.R.; van der Meel R.; Lipid nanoparticle technology for therapeutic gene regulation in the liver. Adv Drug Deliv Rev  2020,159,344-363","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"Pardi N.","year":"2018","unstructured":"Pardi N.; Hogan M.J.; Porter F.W.; Weissman D.; mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov  2018,17(4),261-279","journal-title":"Nat Rev Drug Discov"},{"key":"ref=32","first-page":"277","volume":"40","author":"Ventola C.L.","year":"2015","unstructured":"Ventola C.L.; The antibiotic resistance crisis: Part 1: Causes and threats. PandT  2015,40(4),277-283","journal-title":"PandT"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.envpol.2009.05.051","volume":"157","author":"Martinez J.L.","year":"2009","unstructured":"Martinez J.L.; Environmental pollution by antibiotics and by antibiotic resistance determinants. Environ Pollut  2009,157(11),2893-2902","journal-title":"Environ Pollut"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"Blair J.M.A.","year":"2015","unstructured":"Blair J.M.A.; Webber M.A.; Baylay A.J.; Ogbolu D.O.; Piddock L.J.V.; Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol  2015,13(1),42-51","journal-title":"Nat Rev Microbiol"},{"key":"ref=35","author":"O\u2019Neill J.","year":"2016","unstructured":"O\u2019Neill J.; Tackling drug-resistant infections globally: Final report and recommendations.  Available From:      https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf2016"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s11095-014-1617-7","volume":"32","author":"Pirnay J.P.","year":"2015","unstructured":"Pirnay J.P.; Blasdel B.G.; Bretaudeau L.; Buckling A.; Chanishvili N.; Clark J.R.; Corte-Real S.; Debarbieux L.; Dublanchet A.; De Vos D.; Gabard J.; Garcia M.; Goderdzishvili M.; G&#xF3;rski A.; Hardcastle J.; Huys I.; Kutter E.; Lavigne R.; Merabishvili M.; Olchawa E.; Parikka K.J.; Patey O.; Pouilot F.; Resch G.; Rohde C.; Scheres J.; Skurnik M.; Vaneechoutte M.; Van Parys L.; Verbeken G.; Zizi M.; Van den Eede G.; Quality and safety requirements for sustainable phage therapy products. Pharm Res  2015,32(7),2173-2179","journal-title":"Pharm Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jac\/dku380","volume":"70","author":"Blair J.M.A.","year":"2015","unstructured":"Blair J.M.A.; Smith H.E.; Ricci V.; Lawler A.J.; Thompson L.J.; Piddock L.J.V.; Expression of homologous RND efflux pump genes is dependent upon AcrB expression: Implications for efflux and virulence inhibitor design. J Antimicrob Chemother  2015,70(2),424-431","journal-title":"J Antimicrob Chemother"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1038\/nm1209","volume":"11","author":"Plotkin S.A.","year":"2005","unstructured":"Plotkin S.A.; Vaccines: Past, present and future. Nat Med  2005,11(S4),S5-S11","journal-title":"Nat Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"Doudna J.A.","year":"2014","unstructured":"Doudna J.A.; Charpentier E.; The new frontier of genome engineering with CRISPR-Cas9. Science  2014,346(6213),1258096","journal-title":"Science"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1114397","volume":"311","author":"Nel A","year":"2006","unstructured":"Nel A; Xia T; Madler L; Li N.; Toxic potential of materials at the nanolevel. Science  2006,311(5761),622-7","journal-title":"Science"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1128\/JCM.03099-13","volume":"52","author":"Anderson N.W.","year":"2014","unstructured":"Anderson N.W.; Buchan B.W.; Ledeboer N.A.; Comparison of the BD MAX enteric bacterial panel to routine culture methods for detection of Campylobacter, enterohemorrhagic Escherichia coli (O157), Salmonella, and Shigella isolates in preserved stool specimens. J Clin Microbiol  2014,52(4),1222-1224","journal-title":"J Clin Microbiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/2045-080X.186181","volume":"7","author":"Shankar P.R.","year":"2016","unstructured":"Shankar P.R.; Book review: Tackling drug-resistant infections globally. Arch Pharm Pract  2016,7(3),110-111","journal-title":"Arch Pharm Pract"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"Davies J.","year":"2010","unstructured":"Davies J.; Davies D.; Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev  2010,74(3),417-433","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=44","year":"2017","unstructured":"Global action plan on antimicrobial resistance World Health Organization 2017","journal-title":"Global action plan on antimicrobial resistance"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/cc13948","volume":"18","author":"Spellberg B.","year":"2014","unstructured":"Spellberg B.; The future of antibiotics. Crit Care  2014,18(3),228","journal-title":"Crit Care"},{"key":"ref=46","first-page":"26","volume":"2","author":"Sirisha V.N.","year":"2012","unstructured":"Sirisha V.N.; Liposomes-the potential drug carriers. J Pharm (Cairo)  2012,2(5),26-38","journal-title":"J Pharm (Cairo)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"Makadia H.K.","year":"2011","unstructured":"Makadia H.K.; Siegel S.J.; Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers  2011,3(3),1377-1397","journal-title":"Polymers"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1517\/17425247.2015.1018175","volume":"12","author":"Pridgen E.M.","year":"2015","unstructured":"Pridgen E.M.; Alexis F.; Farokhzad O.C.; Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv  2015,12(9),1459-1473","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=49","doi-asserted-by":"publisher","DOI":"10.1201\/9780138748807","author":"Lasic DD","year":"2019","unstructured":"Lasic DD;  Liposomes in gene delivery  2019","journal-title":"Liposomes in gene delivery"},{"key":"ref=50","first-page":"145","volume":"7","author":"Ghorab M.A.","year":"2015","unstructured":"Ghorab M.A.; Gardouh A.H.; Gad S.H.; Effect of viscosity, surfactant type and concentration on physicochemical properties of solid lipid nanoparticles. Int J Pharm Pharm Sci  2015,7(3),145-153","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/acsabm.8b00821","volume":"2","author":"Zhang C.","year":"2019","unstructured":"Zhang C.; Zhao W.; Bian C.; Hou X.; Deng B.; McComb D.W.; Chen X.; Dong Y.; Antibiotic-derived lipid nanoparticles to treat intracellular Staphylococcus aureus. ACS Appl Bio Mater  2019,2(3),1270-1277","journal-title":"ACS Appl Bio Mater"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/2211738506666180611100416","volume":"6","author":"Shankar R.","year":"2018","unstructured":"Shankar R.; Joshi M.; Pathak K.; Lipid nanoparticles: A novel approach for brain targeting. Pharm Nanotechnol  2018,6(2),81-93","journal-title":"Pharm Nanotechnol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2157-7439.1000e138","volume":"7","author":"S Vaze O.","year":"2016","unstructured":"S Vaze O.; Pharmaceutical nanocarriers (liposomes and micelles) in cancer therapy. J Nanomed Nanotechnol  2016,7(3),1-2","journal-title":"J Nanomed Nanotechnol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bcp.2012.01.008","volume":"83","author":"Hu C.M.J.","year":"2012","unstructured":"Hu C.M.J.; Zhang L.; Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol  2012,83(8),1104-1111","journal-title":"Biochem Pharmacol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.semnuclmed.2009.12.005","volume":"403","author":"Olafsen T","year":"2010","unstructured":"Olafsen T; Wu AM.; Antibody vectors for imaging. Semin Nucl Med  2010,403(3),167-81","journal-title":"Semin Nucl Med"},{"key":"ref=56","first-page":"1","volume":"10","author":"Rassouli A.","year":"2018","unstructured":"Rassouli A.; Al-Qushawi A.; Lipid-based nanoparticles as novel drug delivery systems for antimicrobial agents. Iran J Vet Sci Technol  2018,10(2),1-6","journal-title":"Iran J Vet Sci Technol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1903138","DOI":"10.1002\/advs.201903138","volume":"7","author":"Lin L.","year":"2020","unstructured":"Lin L.; Gong H.; Li R.; Huang J.; Cai M.; Lan T.; Huang W.; Guo Y.; Zhou Z.; An Y.; Chen Z.; Liang L.; Wang Y.; Shuai X.; Zhu K.; Nanodrug with ROS and pH dual sensitivity ameliorates liver fibrosis via multicellular regulation. Adv Sci (Weinh)  2020,7(7),1903138","journal-title":"Adv Sci (Weinh)"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.colsurfb.2017.04.002","volume":"155","author":"Lin J.T.","year":"2017","unstructured":"Lin J.T.; Liu Z.K.; Zhu Q.L.; Rong X.H.; Liang C.L.; Wang J.; Ma D.; Sun J.; Wang G.H.; Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles. Colloids Surf B Biointerfaces  2017,155,41-50","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.foodchem.2017.11.091","volume":"248","author":"Tian H.","year":"2018","unstructured":"Tian H.; Lu Z.; Li D.; Hu J.; Preparation and characterization of citral-loaded solid lipid nanoparticles. Food Chem  2018,248,78-85","journal-title":"Food Chem"},{"key":"ref=60","first-page":"105791","author":"Zein M.A.","year":"2023","unstructured":"Zein M.A.; Asghar B.H.; Almohyawi A.M.; Alqahtani N.F.; Alharbi A.; Alkabli J.; Elshaarawy R.F.; Ismail L.A.; Multifunctional nanocomposites integrated green synthesized amphiphilic chitosan\/thyme extract\/nanosilver for antimicrobial and anti-biofilm applications. React Funct Polym  2023,105791","journal-title":"React Funct Polym"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/21691401.2014.953633","volume":"44","author":"Daraee H.","year":"2016","unstructured":"Daraee H.; Etemadi A.; Kouhi M.; Alimirzalu S.; Akbarzadeh A.; Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol  2016,44(1),381-391","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jconrel.2017.10.024","volume":"268","author":"Li T.F.","year":"2017","unstructured":"Li T.F.; Li K.; Wang C.; Liu X.; Wen Y.; Xu Y.H.; Zhang Q.; Zhao Q.Y.; Shao M.; Li Y.Z.; Han M.; Komatsu N.; Zhao L.; Chen X.; Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. J Control Release  2017,268,128-146","journal-title":"J Control Release"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/mrm.20010","volume":"51","author":"Morawski A.M.","year":"2004","unstructured":"Morawski A.M.; Winter P.M.; Crowder K.C.; Caruthers S.D.; Fuhrhop R.W.; Scott M.J.; Robertson J.D.; Abendschein D.R.; Lanza G.M.; Wickline S.A.; Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med  2004,51(3),480-486","journal-title":"Magn Reson Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"Maeda H.","year":"2000","unstructured":"Maeda H.; Wu J.; Sawa T.; Matsumura Y.; Hori K.; Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release  2000,65(1-2),271-284","journal-title":"J Control Release"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nbt1402","volume":"26","author":"Akinc A.","year":"2008","unstructured":"Akinc A.; Zumbuehl A.; Goldberg M.; Leshchiner E.S.; Busini V.; Hossain N.; Bacallado S.A.; Nguyen D.N.; Fuller J.; Alvarez R.; Borodovsky A.; Borland T.; Constien R.; de Fougerolles A.; Dorkin J.R.; Narayanannair Jayaprakash K.; Jayaraman M.; John M.; Koteliansky V.; Manoharan M.; Nechev L.; Qin J.; Racie T.; Raitcheva D.; Rajeev K.G.; Sah D.W.Y.; Soutschek J.; Toudjarska I.; Vornlocher H.P.; Zimmermann T.S.; Langer R.; Anderson D.G.; A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol  2008,26(5),561-569","journal-title":"Nat Biotechnol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1021\/acs.jafc.5b04559","volume":"64","author":"Loo C.Y.","year":"2016","unstructured":"Loo C.Y.; Rohanizadeh R.; Young P.M.; Traini D.; Cavaliere R.; Whitchurch C.B.; Lee W.H.; Combination of silver nanoparticles and curcumin nanoparticles for enhanced anti-biofilm activities. J Agric Food Chem  2016,64(12),2513-2522","journal-title":"J Agric Food Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1021\/es0522635","volume":"40","author":"Rothen-Rutishauser B.M.","year":"2006","unstructured":"Rothen-Rutishauser B.M.; Sch&#xFC;rch S.; Haenni B.; Kapp N.; Gehr P.; Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol  2006,40(14),4353-4359","journal-title":"Environ Sci Technol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/mt.2011.141","volume":"19","author":"Whitehead K.A.","year":"2011","unstructured":"Whitehead K.A.; Sahay G.; Li G.Z.; Love K.T.; Alabi C.A.; Ma M.; Zurenko C.; Querbes W.; Langer R.S.; Anderson D.G.; Synergistic silencing: Combinations of lipid- like materials for efficacious siRNA delivery. Mol Ther  2011,19(9),1688-1694","journal-title":"Mol Ther"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.3390\/cancers3022597","volume":"3","author":"Postiglione I.","year":"2011","unstructured":"Postiglione I.; Chiaviello A.; Palumbo G.; Enhancing photodynamyc therapy efficacy by combination therapy: Dated, current and oncoming strategies. Cancers  2011,3(2),2597-2629","journal-title":"Cancers"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s10103-021-03422-x","volume":"37","author":"Lavaee F.","year":"2021","unstructured":"Lavaee F.; Motamedifar M.; Rafiee G.; The effect of photodynamic therapy by gold nanoparticles on Streptococcus mutans and biofilm formation: An in vitro study. Lasers Med Sci  2021,37(3),1717-1725","journal-title":"Lasers Med Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4155\/tde.11.68","volume":"2","author":"Foged C.","year":"2011","unstructured":"Foged C.; Subunit vaccines of the future: The need for safe, customized and optimized particulate delivery systems. Ther Deliv  2011,2(8),1057-1077","journal-title":"Ther Deliv"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1039\/C8TB01245H","volume":"6","author":"Li X.","year":"2018","unstructured":"Li X.; Wu B.; Chen H.; Nan K.; Jin Y.; Sun L.; Wang B.; Recent developments in smart antibacterial surfaces to inhibit biofilm formation and bacterial infections. J Mater Chem B Mater Biol Med  2018,6(26),4274-4292","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jconrel.2022.10.038","volume":"352","author":"Zhou Q.","year":"2022","unstructured":"Zhou Q.; Si Z.; Wang K.; Li K.; Hong W.; Zhang Y.; Li P.; Enzyme-triggered smart antimicrobial drug release systems against bacterial infections. J Control Release  2022,352,507-526","journal-title":"J Control Release"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/jcm10081641","volume":"10","author":"Kligman S.","year":"2021","unstructured":"Kligman S.; Ren Z.; Chung C.H.; Perillo M.A.; Chang Y.C.; Koo H.; Zheng Z.; Li C.; The impact of dental implant surface modifications on osseointegration and biofilm formation. J Clin Med  2021,10(8),1641","journal-title":"J Clin Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3390\/nano11102467","volume":"11","author":"Chung S.L.","year":"2021","unstructured":"Chung S.L.; Yee M.S.L.; Hii L.W.; Lim W.M.; Ho M.Y.; Khiew P.S.; Leong C.O.; Advances in nanomaterials used in co-delivery of siRNA and small molecule drugs for cancer treatment. Nanomaterials  2021,11(10),2467","journal-title":"Nanomaterials"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/03639045.2018.1442847","volume":"44","author":"Farhangi M.","year":"2018","unstructured":"Farhangi M.; Kobarfard F.; Mahboubi A.; Vatanara A.; Mortazavi S.A.; Preparation of an optimized ciprofloxacin-loaded chitosan nanomicelle with enhanced antibacterial activity. Drug Dev Ind Pharm  2018,44(8),1273-1284","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1073\/pnas.1016409108","volume":"108","author":"Lee N.","year":"2011","unstructured":"Lee N.; Kim H.; Choi S.H.; Park M.; Kim D.; Kim H.C.; Choi Y.; Lin S.; Kim B.H.; Jung H.S.; Kim H.; Park K.S.; Moon W.K.; Hyeon T.; Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc Natl Acad Sci USA  2011,108(7),2662-2667","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1517\/17425247.2011.584868","volume":"8","author":"Preiss M.R.","year":"2011","unstructured":"Preiss M.R.; Bothun G.D.; Stimuli-responsive liposome- nanoparticle assemblies. Expert Opin Drug Deliv  2011,8(8),1025-1040","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"Wang L.","year":"2017","unstructured":"Wang L.; Hu C.; Shao L.; The antimicrobial activity of nanoparticles: Present situation and prospects for the future. Int J Nanomedicine  2017,12,1227-1249","journal-title":"Int J Nanomedicine"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"125700","DOI":"10.1016\/j.cej.2020.125700","volume":"399","author":"Xie S.","year":"2020","unstructured":"Xie S.; Li S.; Zhang Z.; Chen M.; Ran P.; Li X.; Bacterial ghosts for targeting delivery and subsequent responsive release of ciprofloxacin to destruct intracellular bacteria. Chem Eng J  2020,399,125700","journal-title":"Chem Eng J"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-031-14100-3_6","author":"Rana D.","year":"2023","unstructured":"Rana D.; Salave S.; Patel R.; Khunt D.; Misra M.; Prajapati B.; Patel G.; Patel J.;  Tubercular Drug Delivery Systems: Advances in Treatment of Infectious Diseases  2023,99-121","journal-title":"Tubercular Drug Delivery Systems: Advances in Treatment of Infectious Diseases"},{"key":"ref=82","first-page":"1","volume":"2023","author":"Sethi S.","year":"2023","unstructured":"Sethi S.; Preliminary in vitro hemocompatibility assessment of biopolymeric hydrogels for versatile biomedical applications. Polym Bull  2023,2023,1-24","journal-title":"Polym Bull"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"116457","DOI":"10.1016\/j.envres.2023.116457","volume":"236","author":"Li W.","year":"2023","unstructured":"Li W.; Zheng N.; Zhou Q.; Alqahtani M.S.; Elkamchouchi D.H.; Zhao H.; Lin S.; A state-of-the-art analysis of pharmacological delivery and artificial intelligence techniques for inner ear disease treatment. Environ Res  2023,236(Pt 1),116457","journal-title":"Environ Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"122237","DOI":"10.1016\/j.biomaterials.2023.122237","volume":"301","author":"Zhao Y.","year":"2023","unstructured":"Zhao Y.; He P.; Yao J.; Li M.; Wang B.; Han L.; Huang Z.; Guo C.; Bai J.; Xue F.; Cong Y.; Cai W.; Chu P.K.; Chu C.; pH\/NIR-responsive and self-healing coatings with bacteria killing, osteogenesis, and angiogenesis performances on magnesium alloy. Biomaterials  2023,301,122237","journal-title":"Biomaterials"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"14534","DOI":"10.1039\/D3NJ01822A","volume":"47","author":"Shathi T.S.","year":"2023","unstructured":"Shathi T.S.; Rahman M.A.; Rahman M.A.; Nasiruddin M.; Alim Al-Bari M.A.; Pande S.; Komeda T.; Ul-Hamid A.; Ahmad H.; Karim M.R.; Synthesis and functionalization of zinc phosphate@polyglycidyl methacrylate composites for antimicrobial drug immobilization and controlled release: An in vitro study. New J Chem  2023,47(30),14534-14550","journal-title":"New J Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"102490","DOI":"10.1016\/j.nano.2021.102490","volume":"40","author":"Khalid S.","year":"2022","unstructured":"Khalid S.; Salman S.; Iqbal K.; Rehman F.; Ullah I.; Satoskar A.R.; Khan G.M.; Dar M.J.; Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis. Nanomedicine  2022,40,102490","journal-title":"Nanomedicine"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/pharmaceutics14020370","volume":"14","author":"Natsaridis E.","year":"2022","unstructured":"Natsaridis E.; Gkartziou F.; Mourtas S.; Stuart M.C.A.; Kolonitsiou F.; Klepetsanis P.; Spiliopoulou I.; Antimisiaris S.G.; Moxifloxacin liposomes: Effect of liposome preparation method on physicochemical properties and antimicrobial activity against Staphylococcus epidermidis. Pharmaceutics  2022,14(2),370","journal-title":"Pharmaceutics"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1016\/j.bioactmat.2021.02.038","volume":"6","author":"Shi Y.","year":"2021","unstructured":"Shi Y.; Feng X.; Lin L.; Wang J.; Chi J.; Wu B.; Zhou G.; Yu F.; Xu Q.; Liu D.; Quan G.; Lu C.; Pan X.; Cai J.; Wu C.; Virus-inspired surface-nanoengineered antimicrobial liposome: A potential system to simultaneously achieve high activity and selectivity. Bioact Mater  2021,6(10),3207-3217","journal-title":"Bioact Mater"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijbiomac.2019.12.049","volume":"144","author":"Perveen K.","year":"2020","unstructured":"Perveen K.; Masood F.; Hameed A.; Preparation, characterization and evaluation of antibacterial properties of epirubicin loaded PHB and PHBV nanoparticles. Int J Biol Macromol  2020,144,259-266","journal-title":"Int J Biol Macromol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jiec.2020.05.025","volume":"89","author":"Jayeoye T.J.","year":"2020","unstructured":"Jayeoye T.J.; Nwabor O.F.; Rujiralai T.; Synthesis of highly stable and dispersed silver nanoparticles\/poly(vinyl alcohol-co-ethylene glycol)\/poly(3-aminophenyl boronic acid) nanocomposite: Characterization and antibacterial, hemolytic and cytotoxicity studies. J Ind Eng Chem  2020,89,288-300","journal-title":"J Ind Eng Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tube.2004.11.003","volume":"85","author":"Pandey R.","year":"2005","unstructured":"Pandey R.; Khuller G.K.; Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis  2005,85(4),227-234","journal-title":"Tuberculosis"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jbm.b.30994","volume":"86B","author":"Jain D.","year":"2008","unstructured":"Jain D.; Banerjee R.; Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater  2008,86B(1),105-112","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0378-5173(02)00080-7","volume":"238","author":"Cavalli R.","year":"2002","unstructured":"Cavalli R.; Gasco M.R.; Chetoni P.; Burgalassi S.; Saettone M.F.; Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm  2002,238(1-2),241-245","journal-title":"Int J Pharm"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","volume":"278","author":"Souto E.B.","year":"2004","unstructured":"Souto E.B.; Wissing S.A.; Barbosa C.M.; M&#xFC;ller R.H.; Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm  2004,278(1),71-77","journal-title":"Int J Pharm"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/02652040500162436","volume":"22","author":"Souto E.B.","year":"2005","unstructured":"Souto E.B.; M&#xFC;ller R.H.; SLN and NLC for topical delivery of ketoconazole. J Microencapsul  2005,22(5),501-510","journal-title":"J Microencapsul"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1208\/s12249-009-9199-0","volume":"10","author":"Bhalekar M.R.","year":"2009","unstructured":"Bhalekar M.R.; Pokharkar V.; Madgulkar A.; Patil N.; Patil N.; Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech  2009,10(1),289-296","journal-title":"AAPS PharmSciTech"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1211\/jpp.59.8.0002","volume":"59","author":"Sanna V.","year":"2010","unstructured":"Sanna V.; Gavini E.; Cossu M.; Rassu G.; Giunchedi P.; Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: In vitro characterization, ex vivo and in vivo studies. J Pharm Pharmacol  2010,59(8),1057-1064","journal-title":"J Pharm Pharmacol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.2174\/138161281941131219124517","volume":"19","author":"Serpe L.","year":"2013","unstructured":"Serpe L.; Canaparo R.; Foglietta F.; Zara G.P.; Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs. Curr Pharm Des  2013,19(41),7219-7236","journal-title":"Curr Pharm Des"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"118663","DOI":"10.1016\/j.ijpharm.2019.118663","volume":"570","author":"Yang M.Y.","year":"2019","unstructured":"Yang M.Y.; Zhao R.R.; Fang Y.F.; Jiang J.L.; Yuan X.T.; Shao J.W.; Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy. Int J Pharm  2019,570,118663","journal-title":"Int J Pharm"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1208\/s12248-012-9330-0","volume":"14","author":"Sawant R.R.","year":"2012","unstructured":"Sawant R.R.; Torchilin V.P.; Challenges in development of targeted liposomal therapeutics. AAPS J  2012,14(2),303-315","journal-title":"AAPS J"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1468-2494.2008.00433.x","volume":"30","author":"Souto E.B.","year":"2008","unstructured":"Souto E.B.; M&#xFC;ller R.H.; Cosmetic features and applications of lipid nanoparticles (SLN, NLC ). Int J Cosmet Sci  2008,30(3),157-165","journal-title":"Int J Cosmet Sci"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2174\/1871527313666140806145540","volume":"13","author":"Ruozi B","year":"2014","unstructured":"Ruozi B; Belletti D; Forni F; Sharma A; Muresanu D; Mossler H.; Poly (D,L-lactide-co-glycolide) nanoparticles loaded with cerebrolysin display neuroprotective activity in a rat model of concussive head injury. CNS Neurol Disord Drug Targets  2014,13(8),1475-82","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1016\/j.xphs.2020.06.021","volume":"109","author":"Islam Y.","year":"2020","unstructured":"Islam Y.; Khalid A.; Pluchino S.; Sivakumaran M.; Teixid&#xF2; M.; Leach A.; Fatokun A.A.; Downing J.; Coxon C.; Ehtezazi T.; Development of brain targeting peptide based MMP-9 inhibiting nanoparticles for the treatment of brain diseases with elevated MMP-9 activity. J Pharm Sci  2020,109(10),3134-3144","journal-title":"J Pharm Sci"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673314366240712105637","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/231979\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673314366240712105637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T11:35:55Z","timestamp":1742902555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/231979\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":103,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673314366240712105637","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}